Related Experiment Videos
Recurrence to persistence: Inflammatory markers in pediatric rheumatic heart disease
Lalan Kumar1, Sakshi Sachdeva1, Dheeraj Deo Bhatt1
1Department of Pediatrics, ABVIMS and Dr RML Hospital, New Delhi, India.
Background:
Studies in adults with chronic rheumatic heart disease (RHD) suggest persistence of elevated inflammatory markers, indicating a potential role of ongoing inflammation in disease chronicity. However, similar data in the pediatric population are lacking.
Methods:
A cross-sectional observational study was conducted in the Division of Pediatric Cardiology at a tertiary care hospital in North India from August 2022 to February 2024. Forty-three patients with RHD <18 years were enrolled. Comprehensive history taking and clinical examinations were conducted. Blood samples were collected to evaluate C-reactive protein (CRP), neutrophil-to-lymphocyte ratio, interleukin-6 (IL-6), IL-17, and tumor necrosis factor alpha (TNF-α) levels. Inflammatory marker levels were compared with American College of Cardiology (ACC) valvular heart disease (VHD) stage.
Results:
Mean age of participants was 13.14 ± 3.17 years. Mean duration of disease was 3.23 ± 1.98 years. The CRP was elevated in 37.2% (n = 16) patients. IL-6, IL-17, and TNF-α were elevated in all patients. IL-6 (P = 0.036) and IL-17 (P = 0.008) showed significant association with ACC VHD stage.
Conclusions:
Pediatric RHD patients exhibit elevated blood inflammatory markers in the absence of acute rheumatic fever. Targeting this chronic inflammation could potentially slow progression of RHD.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Pericarditis II: Clinical Features and Diagnostic Tests
Endocarditis III: Medical Management